|
|
|
51-200 employees
View all
|
|
pharmaceuticals
|
|
3200 Walnut Street,Boulder,CO,US
|
|
Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC.
|
Array BioPharma Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
66.67%
|
The widely used Array BioPharma Inc. email format is {first}.{last} (e.g. [email protected]) with 66.67% adoption across the company.
To contact Array BioPharma Inc. customer service number in your country click here to find.
Theperemedy Carruth is the CEO of Array BioPharma Inc..
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.